Dr. Michael Ray Delong, MD

Dr. Delong practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Delong's NPI, 1104246339, was assigned on April 28, 2014. Dr. Delong graduated from Duke University School Of Medicine in 2014. Dr. Delong's California license number on file is A142610.

Dr. Delong's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Delong's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Delong is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Plastic Surgery Associates. Dmand AI also links Dr. Delong to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delong practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Delong's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Delong is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Delong has a license on file in California.

Dmand AI lists chronic skin ulcer, head wound and removal of damaged skin or skin graft among the conditions Dr. Delong treats.

CMS data shows 42 Medicare services from Dr. Delong across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $3,356 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Dr. Delong in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delong's median patient age at 50, with 74% women.

In 2017, Dr. Delong wrote 53 Medicare Part D claims. They cover 2 drugs, with $492 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Delong for performance year 2024, reported as part of a group. Dr. Delong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Delong as offering telehealth. CMS counts 28 procedures of mastectomy by Dr. Delong, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Delong in 2024.

CMS Open Payments shows 27 general payments to Dr. Delong from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. AxoGen paid the most, $830.

Dr. Delong graduated from Duke University School Of Medicine in 2014.

Dr. Delong is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.